Atlas Trials

Azienda USL Reggio Emilia - IRCCS

101 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Azienda USL Reggio Emilia - IRCCS

RecordFirmDate
PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive Cases (NCT02324296)Azienda USL Reggio Emilia - IRCCS1998-12-01
← Previous

Track Azienda USL Reggio Emilia - IRCCS automatically

Every clearance here is in the API, with alerts when new ones post.